Trials / Conditions / Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
3 registered clinical trials studyying Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase II Study of RC1416 Injection in COPD NCT07402551 | Nanjing RegeneCore Biotech Co., Ltd. | Phase 2 |
| Active Not Recruiting | Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW19 NCT06175351 | Mabwell (Shanghai) Bioscience Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1 NCT01584505 | Chiesi Farmaceutici S.p.A. | Phase 2 |